Shaving Kit Suppliers and Manufacturers

This recertified Medical MD Oxygen Cylinder is perfect for professional or personal home oxygen use. With a 14.6 cu ft capacity,this medical oxygen cylinder is perfect for portability and smaller spaces. This lightweight, easy to transport aluminum requalified cylinder is DOT approved, and ready for medical or industrial use. It comes fitted with a CGA870 post valve installed and a freshly painted dome in a Medical Green color for easy identification. PREMIUM CONSTRUCTION Reconditioned High-quality aluminum body Clearcoat protected Medical green rust-resistant painted dome CGA870 medical post valve installed Approximately 4.4â?³ in diameter x 16.3â?³ in height* (with valve) Weighs approximately 6 pounds Capacity 14.6 cubic foot 2015 PSI service / 3360 PSI test pressure Stamped DOT-3AL2015 5-year retest interval Recertified test within 180 days prior to shipment

Technique Parameter Oxygen flow rate .. 1L-5L Oxygen concentration .. 93% + 3% Rated voltage / Power .. AC220+V 22V ,50Hz + 1Hz Material .. Plastic Oxygen concentration .. 0.5-3L/min + 90% Flow fluctuation .. 0.7L/min Atomization amount .. + 0.2ml/min environment temperature .. 5-40 humidity range .. 80% Atmospheric pressure range .86kpa -- 106kpa Size .. L448*W245*H492 Weight .. 14.5g 1. Headset type components (optional) 2. Nasal tube assembly (optional) 3. Atomizer assembly

Technique Parameter Oxygen flow rate .. 1L-5L Oxygen concentration .. 93% + 3% Rated voltage / Power .. AC220V + 22V ,50Hz + 1Hz Material .. Plastic Oxygen concentration .. 0.5-3L/min 90% Flow fluctuation .. 0.7L/min Atomization amount .. 0.2ml/min environment temperature .. 5-40 humidity range .. 80% Atmospheric pressure range .. 86kpa -- 106kpa Size .. L448*W245*H492 Weight .. 14.5g 1. Headset type components (optional) 2. Nasal tube assembly (optional) 3. Atomizer assembly

Oxygen Concentrator Intelligent self-checking system with error code showing in LCD Super low noise 24 Hours Continuous Working Long lifespan of Molecular Sieves

Oxygen Concentrator 0-10L/min hot sale manufacturer low noise self-cchecking oxygen-concentrator Intelligent self-checking system with error code showing in LCD Super low noise 24 Hours Continuous Working Long lifespan of Molecular Sieves

-Oxygen Concentrator Brand: yuwell Origin: China Price: USD220/FOB China Payment: TT30%-70% against SGS -Flow Range: 5L/min -Maximum outlet pressure: 40-70kpa -Sound Level: 52 dB(A) -Input power: 400VA -N.W: 16.6kg (36.6Ibs) -Dimension: 39*24.5*50(cm) -Minimum operating time: 30min

Our Rapid Typhoid Testing Kit is a cutting-edge solution for swift and accurate diagnosis of typhoid fever. This advanced kit is designed for quick detection of the Salmonella Typhi bacteria, streamlining the diagnostic process for healthcare professionals. With a user-friendly approach, it requires a small blood sample and delivers results within minutes, enabling rapid treatment decisions. The kit exhibits exceptional sensitivity and specificity, ensuring reliable diagnoses even in low-infection scenarios. Its compact, portable design makes it ideal for remote and resource-limited areas. Trust our Rapid Typhoid Testing Kit for fast, dependable, and life-saving typhoid fever diagnosis, enhancing patient care and containment of this infectious disease.

Introducing our Rapid Malaria Testing Kit, a breakthrough in diagnosing malaria with speed and accuracy. This cutting-edge kit is designed for easy and quick detection of the malaria parasite, revolutionizing the way healthcare professionals identify this life-threatening disease. With a user-friendly approach, it requires only a small blood sample to deliver results within minutes, enabling swift and informed medical decisions. Our kit boasts high sensitivity and specificity, ensuring reliable diagnoses even in low-infection scenarios. Its compact design and portability make it ideal for remote and resource-limited settings. Trust our Rapid Malaria Testing Kit for fast, dependable, and life-saving malaria diagnosis, providing critical support in the fight against this global health challenge.

PC-PASS Protein Characterization Analysis Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment

Biomarker Diseases Diagnosis Blood Tests Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Advantages of proteomics-based early diagnosis: Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.

Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.

PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS). Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc. PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics. Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable. With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.

Exo-PASS Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package. Exosome RNA Sequencing: PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods. Exosome Lipidomics: We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years. Exosome Proteomics: PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.

Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood. High diagnostic accuracy : Quantitative values of biomarkers are measured and entered in a unique algorithm with applied AI. Convenience : No burden of inconvenience caused due to the use of a separate diagnostic device other than blood sampling Efficiency: Provides diagnosis opportunities to more people in situations where personnel and devices are limited

MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.

Malaria Antigen PF/PV Card Test

We have 50mil indicaid covid test kit otg usa.

Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) is used for in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs, oropharyngeal swabs and nasal swabs from individuals who are suspected of SARS-CoV-2 by their healthcare provider within the first seven days of symptom onset.

Quick Details Pressure : High Place of Origin : Hubei, China Model Number : 20Mpa-356(7.7)mm-150L CNG Compressed Natural Gas Material : Steel, 34CrMo4 Steel Brand Name : SINOGES or OEM Branded Use : Vehicle Mother Station Transport Application : Vehicle Mother Station Transport Working pressure : 20 MPa | 200 Bar | 2901 psi Test Pressure : 37.5 MPa | 375 Bar | 5439 psi Outer Diameter : 356 mm | 14 inch Wall Thickness : 7.7 mm | 0.3 inch Water capacity : 150 L | 9154 in3 Cylinder Height : 1851 mm | 72.9 inch Cylinder Weight : 141.1 kg | 311 lb Certification : ISO 9809-1 TPED Supply Ability Supply Ability : 2646 Piece/Pieces per Week Packaging & Delivery Packaging Details : Wood Pallet Packing Port : Shanghai Picture Example : package-imgpackage-img Lead Time: Quantity(Pieces) 1 - 1 2 - 378 379 - 1134 >1134 Est. Time(days) 15 35 45 To be negotiated